BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21960453)

  • 1. Prevalence of human papillomavirus in women with invasive cervical carcinoma by HIV status in Kenya and South Africa.
    De Vuyst H; Ndirangu G; Moodley M; Tenet V; Estambale B; Meijer CJ; Snijders PJ; Clifford G; Franceschi S
    Int J Cancer; 2012 Aug; 131(4):949-55. PubMed ID: 21960453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unique human papillomavirus-type distribution in South African women with invasive cervical cancer and the effect of human immunodeficiency virus infection.
    van Aardt MC; Dreyer G; Pienaar HF; Karlsen F; Hovland S; Richter KL; Becker P
    Int J Gynecol Cancer; 2015 Jun; 25(5):919-25. PubMed ID: 25950128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of human papillomavirus (HPV) types in cervical cancer 2003-2008 in Stockholm, Sweden, before public HPV vaccination.
    Du J; Näsman A; Carlson JW; Ramqvist T; Dalianis T
    Acta Oncol; 2011 Nov; 50(8):1215-9. PubMed ID: 21726177
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus types in women with invasive cervical carcinoma by HIV status in Kenya.
    De Vuyst H; Gichangi P; Estambale B; Njuguna E; Franceschi S; Temmerman M
    Int J Cancer; 2008 Jan; 122(1):244-6. PubMed ID: 17764116
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women.
    Strickler HD; Burk RD; Fazzari M; Anastos K; Minkoff H; Massad LS; Hall C; Bacon M; Levine AM; Watts DH; Silverberg MJ; Xue X; Schlecht NF; Melnick S; Palefsky JM
    J Natl Cancer Inst; 2005 Apr; 97(8):577-86. PubMed ID: 15840880
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study.
    de Sanjose S; Quint WG; Alemany L; Geraets DT; Klaustermeier JE; Lloveras B; Tous S; Felix A; Bravo LE; Shin HR; Vallejos CS; de Ruiz PA; Lima MA; Guimera N; Clavero O; Alejo M; Llombart-Bosch A; Cheng-Yang C; Tatti SA; Kasamatsu E; Iljazovic E; Odida M; Prado R; Seoud M; Grce M; Usubutun A; Jain A; Suarez GA; Lombardi LE; Banjo A; Menéndez C; Domingo EJ; Velasco J; Nessa A; Chichareon SC; Qiao YL; Lerma E; Garland SM; Sasagawa T; Ferrera A; Hammouda D; Mariani L; Pelayo A; Steiner I; Oliva E; Meijer CJ; Al-Jassar WF; Cruz E; Wright TC; Puras A; Llave CL; Tzardi M; Agorastos T; Garcia-Barriola V; Clavel C; Ordi J; Andújar M; Castellsagué X; Sánchez GI; Nowakowski AM; Bornstein J; Muñoz N; Bosch FX;
    Lancet Oncol; 2010 Nov; 11(11):1048-56. PubMed ID: 20952254
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incident high-grade squamous intraepithelial lesions in Senegalese women with and without human immunodeficiency virus type 1 (HIV-1) and HIV-2.
    Hawes SE; Critchlow CW; Sow PS; Touré P; N'Doye I; Diop A; Kuypers JM; Kasse AA; Kiviat NB
    J Natl Cancer Inst; 2006 Jan; 98(2):100-9. PubMed ID: 16418512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of HPV DNA testing in cervical exfoliated cells and tissue biopsies among HIV-positive women in Kenya.
    De Vuyst H; Chung MH; Baussano I; Mugo NR; Tenet V; van Kemenade FJ; Rana FS; Sakr SR; Meijer CJ; Snijders PJ; Franceschi S
    Int J Cancer; 2013 Sep; 133(6):1441-6. PubMed ID: 23444059
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased prevalence of JC polyomavirus in cervical carcinomas from women infected with HIV.
    Alosaimi B; Hampson L; He X; Maranga IO; Oliver AW; Hampson IN
    J Med Virol; 2014 Apr; 86(4):672-7. PubMed ID: 24374981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: a partially-blind randomised placebo-controlled study.
    Denny L; Hendricks B; Gordon C; Thomas F; Hezareh M; Dobbelaere K; Durand C; Hervé C; Descamps D
    Vaccine; 2013 Nov; 31(48):5745-53. PubMed ID: 24091311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of HIV Infection on Human Papillomavirus Types Causing Invasive Cervical Cancer in Africa.
    Clifford GM; de Vuyst H; Tenet V; Plummer M; Tully S; Franceschi S
    J Acquir Immune Defic Syndr; 2016 Nov; 73(3):332-339. PubMed ID: 27331659
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cervical and oral human papillomavirus types in HIV-1 positive and negative women with cervical disease in South Africa.
    Marais DJ; Passmore JA; Denny L; Sampson C; Allan BR; Williamson AL
    J Med Virol; 2008 Jun; 80(6):953-9. PubMed ID: 18428143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Performance of visual inspection with acetic acid and human papillomavirus testing for detection of high-grade cervical lesions in HIV positive and HIV negative Tanzanian women.
    Dartell MA; Rasch V; Iftner T; Kahesa C; Mwaiselage JD; Junge J; Gernow A; Ejlersen SF; Munk C; Kjaer SK
    Int J Cancer; 2014 Aug; 135(4):896-904. PubMed ID: 24391021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccine-related HPV genotypes in women with and without cervical cancer in Mozambique: burden and potential for prevention.
    Castellsagué X; Klaustermeier J; Carrilho C; Albero G; Sacarlal J; Quint W; Kleter B; Lloveras B; Ismail MR; de Sanjosé S; Bosch FX; Alonso P; Menéndez C
    Int J Cancer; 2008 Apr; 122(8):1901-4. PubMed ID: 18076064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus infection in Ulaanbaatar, Mongolia: a population-based study.
    Dondog B; Clifford GM; Vaccarella S; Waterboer T; Unurjargal D; Avirmed D; Enkhtuya S; Kommoss F; Wentzensen N; Snijders PJ; Meijer CJ; Franceschi S; Pawlita M
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1731-8. PubMed ID: 18628425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human papillomavirus genotype distribution in invasive cervical cancer in Bosnia and Herzegovina.
    Iljazović E; Mena M; Tous S; Alemany L; Omeragić F; Sadiković A; Clavero O; Vergara M; Bosch FX; de Sanjosé S
    Cancer Epidemiol; 2014 Oct; 38(5):504-10. PubMed ID: 25130915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human papillomavirus distribution in invasive cervical carcinoma in sub-Saharan Africa: could HIV explain the differences?
    Ndiaye C; Alemany L; Ndiaye N; Kamaté B; Diop Y; Odida M; Banjo K; Tous S; Klaustermeier JE; Clavero O; Castellsagué X; Bosch FX; Trottier H; de Sanjosé S
    Trop Med Int Health; 2012 Dec; 17(12):1432-40. PubMed ID: 23107344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of Cervical Squamous Intraepithelial Lesions in HIV Infected Women in Kenya: a cross-Sectional Study.
    Memiah P; Makokha V; Mbuthia W; Kiiru GW; Agbor S; Odhiambo F; Ojoo S; Mbizo J; Muhula S; Mahasi G; Biadgilign S
    Afr J Reprod Health; 2015 Mar; 19(1):133-9. PubMed ID: 26103703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human papillomavirus DNA in uterine cervix squamous cell carcinoma and adenocarcinoma detected by polymerase chain reaction.
    Iwasawa A; Nieminen P; Lehtinen M; Paavonen J
    Cancer; 1996 Jun; 77(11):2275-9. PubMed ID: 8635095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Worldwide human papillomavirus etiology of cervical adenocarcinoma and its cofactors: implications for screening and prevention.
    Castellsagué X; Díaz M; de Sanjosé S; Muñoz N; Herrero R; Franceschi S; Peeling RW; Ashley R; Smith JS; Snijders PJ; Meijer CJ; Bosch FX;
    J Natl Cancer Inst; 2006 Mar; 98(5):303-15. PubMed ID: 16507827
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.